Clinical Trial Update: Evaluating Tibolone Add-back in Patients With Endometriosis and Fibroids

View source ↗

Summary

A clinical trial evaluating tibolone add-back in patients with endometriosis and uterine fibroids has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis
• Uterine Fibroids

Drugs mentioned

• Tibolone (tibolone)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Endometriosis, Fibroids | Status: WITHDRAWN